245 related articles for article (PubMed ID: 16673296)
61. Hepatitis B virus sensitizes hepatocytes to complement-dependent cytotoxicity through downregulating CD59.
Qu Z; Liang X; Liu Y; Du J; Liu S; Sun W
Mol Immunol; 2009 Dec; 47(2-3):283-9. PubMed ID: 19804910
[TBL] [Abstract][Full Text] [Related]
62. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
Sun Y; Li Z; Li L; Li J; Liu X; Li W
Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
[TBL] [Abstract][Full Text] [Related]
63. [Relevance of a technic for studying hepatitis B virus replication in developing countries].
Martet G; Klotz F; Nicolas P; Lecamus JL
Med Trop (Mars); 1989; 49(2):175-7. PubMed ID: 2796703
[TBL] [Abstract][Full Text] [Related]
64. The HBSP gene is expressed during HBV replication, and its coded BH3-containing spliced viral protein induces apoptosis in HepG2 cells.
Lu YW; Tan TL; Chan V; Chen WN
Biochem Biophys Res Commun; 2006 Dec; 351(1):64-70. PubMed ID: 17049490
[TBL] [Abstract][Full Text] [Related]
65. Novel robust in vitro hepatitis B virus infection model using fresh human hepatocytes isolated from humanized mice.
Ishida Y; Yamasaki C; Yanagi A; Yoshizane Y; Fujikawa K; Watashi K; Abe H; Wakita T; Hayes CN; Chayama K; Tateno C
Am J Pathol; 2015 May; 185(5):1275-85. PubMed ID: 25791527
[TBL] [Abstract][Full Text] [Related]
66. Differentiated umbilical cord matrix stem cells as a new in vitro model to study early events during hepatitis B virus infection.
Paganelli M; Dallmeier K; Nyabi O; Scheers I; Kabamba B; Neyts J; Goubau P; Najimi M; Sokal EM
Hepatology; 2013 Jan; 57(1):59-69. PubMed ID: 22898823
[TBL] [Abstract][Full Text] [Related]
67. Fibronectin is essential for hepatitis B virus propagation in vitro: may be a potential cellular target?
Yang J; Ding X; Zhang Y; Bo X; Zhang M; Wang S
Biochem Biophys Res Commun; 2006 Jun; 344(3):757-64. PubMed ID: 16631116
[TBL] [Abstract][Full Text] [Related]
68. Hepatocytes proteomic alteration and seroproteome analysis of HBV-transgenic mice.
Ding C; Wei H; Sun R; Zhang J; Tian Z
Proteomics; 2009 Jan; 9(1):87-105. PubMed ID: 19053081
[TBL] [Abstract][Full Text] [Related]
69. Immunocompetent nontransgenic mouse models for studying hepatitis B virus immune responses.
Tzeng HT; Hsu PN; Chen PJ
J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():116-9. PubMed ID: 23855306
[TBL] [Abstract][Full Text] [Related]
70. Human bone marrow mesenchymal stem cells are resistant to HBV infection during differentiation into hepatocytes in vivo and in vitro.
Xie C; Zheng YB; Zhu HP; Peng L; Gao ZL
Cell Biol Int; 2009 Apr; 33(4):493-500. PubMed ID: 19272332
[TBL] [Abstract][Full Text] [Related]
71. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection.
Huang LR; Wu HL; Chen PJ; Chen DS
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17862-7. PubMed ID: 17095599
[TBL] [Abstract][Full Text] [Related]
72. Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs.
Ding XR; Yang J; Sun DC; Lou SK; Wang SQ
Pharmacogenomics J; 2008 Feb; 8(1):61-70. PubMed ID: 17505500
[TBL] [Abstract][Full Text] [Related]
73. Co-replication analyses of naturally occurring defective hepatitis B virus variants with wild-type.
Märschenz S; Brinckmann A; Nürnberg P; Krüger DH; Günther S; Meisel H
Virology; 2008 Mar; 372(2):247-59. PubMed ID: 18061229
[TBL] [Abstract][Full Text] [Related]
74. GTPase activity is not essential for the interferon-inducible MxA protein to inhibit the replication of hepatitis B virus.
Yu Z; Wang Z; Chen J; Li H; Lin Z; Zhang F; Zhou Y; Hou J
Arch Virol; 2008; 153(9):1677-84. PubMed ID: 18668195
[TBL] [Abstract][Full Text] [Related]
75. [Occult hepatitis B virus infection in chronic viral hepatitis patients with non-A to E hepatitis virus infection].
Shang QH; Yu JG; Xu CZ; An Y; Liu FY; Sun SC; Zhang GS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):440-2. PubMed ID: 19544639
[TBL] [Abstract][Full Text] [Related]
76. Partial Hepatectomy and Castration of HBV Transgenic Mice.
Tian Y; Ou JJ
Methods Mol Biol; 2017; 1540():259-266. PubMed ID: 27975324
[TBL] [Abstract][Full Text] [Related]
77. Duck hepatitis B virus: an invaluable model system for HBV infection.
Schultz U; Grgacic E; Nassal M
Adv Virus Res; 2004; 63():1-70. PubMed ID: 15530560
[No Abstract] [Full Text] [Related]
78. Animal models for the study of HBV replication and its variants.
Dandri M; Volz TK; Lütgehetmann M; Petersen J
J Clin Virol; 2005 Dec; 34 Suppl 1():S54-62. PubMed ID: 16461225
[TBL] [Abstract][Full Text] [Related]
79. Advances and Challenges in Studying Hepatitis B Virus In Vitro.
Witt-Kehati D; Bitton Alaluf M; Shlomai A
Viruses; 2016 Jan; 8(1):. PubMed ID: 26784218
[TBL] [Abstract][Full Text] [Related]
80. Hepatocytes transduced with human TERT gene acquire a prolonged lifespan in culture and retain permissiveness to hepatitis B virus.
Lv LP; Kong YL; Yan F; Ma P; Zhou XP; Zhang YY; Wen DQ; Yu XL; Zhang HY; Zhou H; Xu JB
Acta Virol; 2013; 57(3):305-11. PubMed ID: 24020756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
